相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative ex vivo, in vitro and in silico analyses of a CFTR splicing mutation: Importance of functional studies to establish disease liability of mutations
Anabela S. Ramalho et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Improvement of SMN2 Pre-mRNA Processing Mediated by Exon-Specific U1 Small Nuclear RNA
Andrea Dal Mas et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients
M. D. Amaral
JOURNAL OF INTERNAL MEDICINE (2015)
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
Scott C. Bell et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Protein Traffic Disorders: an Effective High-Throughput Fluorescence Microscopy Pipeline for Drug Discovery
Hugo M. Botelho et al.
SCIENTIFIC REPORTS (2015)
Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis
Laia Masvidal et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2014)
New developments in exon skipping and splice modulation therapies for neuromuscular diseases
Aleksander Touznik et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Experimental Assessment of Splicing Variants Using Expression Minigenes and Comparison with In Silico Predictions
Neeraj Sharma et al.
HUMAN MUTATION (2014)
Cystic fibrosis: Toward personalized therapies
Pauline T. Ikpa et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
HGF Stimulation of Rac1 Signaling Enhances Pharmacological Correction of the Most Prevalent Cystic Fibrosis Mutant F508del-CFTR
Sonia Moniz et al.
ACS CHEMICAL BIOLOGY (2013)
Pick one, but be quick: 5′ splice sites and the problems of too many choices
Xavier Roca et al.
GENES & DEVELOPMENT (2013)
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
Patrick R. Sosnay et al.
NATURE GENETICS (2013)
Exon and intron definition in pre-mRNA splicing
Laura De Conti et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2013)
Management of comorbidities in older patients with cystic fibrosis
Barry J. Plant et al.
LANCET RESPIRATORY MEDICINE (2013)
Splice Modulating Therapies for Human Disease
Pietro Spitali et al.
CELL (2012)
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects
Eugenio Fernandez Alanis et al.
HUMAN MOLECULAR GENETICS (2012)
Analysis of alternative splicing of cassette exons at single-cell level using two fluorescent proteins
Nadya G. Gurskaya et al.
NUCLEIC ACIDS RESEARCH (2012)
Genes, Mutations, and Human Inherited Disease at the Dawn of the Age of Personalized Genomics
David N. Cooper et al.
HUMAN MUTATION (2010)
The Spliceosome: Design Principles of a Dynamic RNP Machine
Markus C. Wahl et al.
CELL (2009)
Substances that can change alternative splice-site selection
Chiranthani Sumanasekera et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
A high-throughout screening strategy identifies cardiotonic steroids as alternative splicing modulators
Peter Stoilov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia
Matthew M. Hims et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron
NK Singh et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation
M Nissim-Rafinia et al.
EMBO REPORTS (2004)
EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia
SL Anderson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis
AS Ramalho et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis
JY Choi et al.
NATURE (2001)
分享论文
